Third Rock Ventures takes aggressive approach to biotech

Third Rock VenturesThird Rock Ventures is taking an aggressive approach to biotech start-ups, investing $1.3 billion in 32 companies since 2006. Read the article from MedCity News here.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.